News
Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...
Bayer submits New Drug Application (NDA) for gadoquatrane: The investigational macrocyclic gadolinium-based contrast agent is designed for contrast-enhanced MRI of the central nervous system and other ...
Medical imaging plays a significant role in clinical diagnosis, but the use of low radiation doses in CT imaging can lead to poor image resolution and precise diagnosis. In this investigation, a novel ...
Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs By Solve M.E. Jun 17, 2025 Updated Jun 17, 2025 ...
This is a single-arm, Simon 2-stage trial. Patients with synovial sarcomas who had progressed on at least two lines were administered daily regorafenib (80/120 mg alternating once daily per orally).
This can result in side-effects like diarrhoea, vomiting, or even pancreatitis. The likelihood of the latter increases with the size of the dose, according to the professor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results